Boehringer Ingelheim ( Boehringer-Ingelheim )

Boehringer-Ingelheim

Boehringer-Ingelheim's picture

About Boehringer Ingelheim

Boehringer Ingelheim is a global group of companies embracing many cultures and diverse societies. Learn more about the financial highlights, the corporate vision, the organisation, the Board of Managing Directors and the company's history as well as our engagement for scientific, cultural and environmental purposes.

Boehringer-Ingelheim press release, blog etc

09/13/2018 - 14:58 Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies
09/10/2018 - 10:19 Changes to the Leadership of Boehringer Ingelheims Corporate Department Medicine
09/04/2018 - 23:21 Boehringer Ingelheim launches the first liquid solution for hypertension in cats
09/03/2018 - 23:17 Boehringer Ingelheim and Tsinghua University Team up to Develop Novel Treatment Approaches that Rally the Immune System Against Infectious Diseases
09/03/2018 - 15:37 Boehringer Ingelheim Biopharmaceuticals China supports BeiGene in its China NDA submission of anti-PD-1 antibody, tislelizumab
08/21/2018 - 16:55 New tablet production facility in Ingelheim: Centerpiece for global launches
08/20/2018 - 18:32 Development partner Boehringer Ingelheim supplies clinical material manufactured in China for new cancer drug
08/02/2018 - 16:48 Boehringer Ingelheim launches the initiative In Reach Africa to address key healthcare infrastructure and access priorities across Africa
08/01/2018 - 16:08 Boehringer Ingelheim achieves modest growth in the first half of 2018
07/10/2018 - 05:44 Boehringer Ingelheim invests more than 200 million to establish strategic production center for Veterinary Public Health in France
07/04/2018 - 14:35 Boehringer Ingelheim extends one-stop-shop service with new fill & finish capabilities in China
06/29/2018 - 18:29 World Scleroderma Day 2018 - Families open up about supporting a loved one with scleroderma, in new video series
06/21/2018 - 22:13 Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center
06/18/2018 - 14:51 Boosting animal welfare for small animals: Boehringer Ingelheim expands European Metacam indication to guinea pigs
05/17/2018 - 00:11 Boehringer Ingelheim demonstrates its commitment to farm animal well-being
05/15/2018 - 04:59 Boehringer Ingelheim inaugurates its new integrated Asian Veterinary Research & Development Centre
04/25/2018 - 04:32 Boehringer Ingelheim R&D pushes to transcend disease boundaries
04/25/2018 - 03:11 Boehringer Ingelheim has a very successful 2017 financial year